Liraglutide is a glucagon-like peptide-1 receptor (GLP-1R) agonist — a peptide analogue of the endogenous incretin hormone GLP-1. In the trial records provided, it is investigated in the context of opioid use disorder and in obese women with polycystic ovary syndrome (PCOS), reflecting its mechanism of acting on GLP-1 receptors.
FDA-approved as Liraglutide, Victoza, Xultophy 100/3.6, Saxenda.
Last reviewed October 13, 2026
The calculator takes vial mass, BAC water volume and your target dose, and returns the exact draw on a U-40, U-50 or U-100 insulin syringe. It does the arithmetic; it does not suggest what the dose should be.
Open the reconstitution calculator →